InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the detailed record of transactions filed by Aurora Daljit Singh. Director active across 1 company, notably Neumora Therapeutics, Inc.. Cumulatively, 3 disclosures have been recorded. Split: 0 buy · 1 sell. Total volume traded: €14k. History available since 14 February 2024. The latest transaction was filed on 18 February 2025 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
3 of 3 declarations